Coherus Biosciences | CHRS - Trade Creditors


Coherus Biosciences reported $9.91M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
ALKERMES USD 107.95M 39.95M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amarin USD 36.71M 8M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Baxter International USD 999M 46M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Fujifilm JPY 308.06B 17.41B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
Merck USD 4.15B 102M Sep/2025
Myriad Genetics USD 31.8M 900K Sep/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Xencor USD 10.83M 1.75M Dec/2025
Zoetis USD 487M 77M Dec/2025